Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Squalene is a natural 30-carbon isoprenoid compound and triterpene with the formula C₃₀H₅₀. It was originally obtained from shark liver oil but is also found in plants, fungi, and produced endogenously in humans as an intermediate metabolite in cholesterol synthesis. Squalene is used as a moisturizing agent in cosmetics due to its similarity to natural skin oils, providing hydration and protection against irritation. In pharmaceuticals, it serves as an adjuvant in vaccines (e.g., influenza vaccines), enhancing immune response by facilitating antigen presentation to immune cells such as macrophages and dendritic cells. Squalene has antioxidant properties and may contribute to cardiovascular health by improving lipid profiles[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on squalene.